U.S., March 13 -- ClinicalTrials.gov registry received information related to the study (NCT07468500) titled 'Real World Adherence of PCSK9 Targeted Therapy' on March 05.
Brief Summary: Retrospective observational cohort study to compare medication adherence at 12 months between patients in Japan with dyslipidemia and/or hypercholesterolemia (familial and non-familial hypercholesterolemia) who newly initiate inclisiran versus those who newly initiate evolocumab.
Study Start Date: March 15
Study Type: OBSERVATIONAL
Condition:
Dyslipidemia
Hypercholesterolemia
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Novartis Pharmaceuticals
Published by HT Digital Content Services with permission from Health Daily Digest....